Hybrid compounds as new Bcr/Abl inhibitors
Wang, Deping, Zhang, Zhang, Lu, Xiaoyun, Feng, Yubing, Luo, Kun, Gan, Jirong, Yingxue, Liu, Wan, Junting, Li, Xiang, Zhang, Fengxiang, Tu, Zhengchao, Cai, Qian, Ren, Xiaomei, Ding, Ke
Published in Bioorganic & medicinal chemistry letters (01.04.2011)
Published in Bioorganic & medicinal chemistry letters (01.04.2011)
Get full text
Journal Article
Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region–Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib
Ren, Xiaomei, Pan, Xiaofen, Zhang, Zhang, Wang, Deping, Lu, Xiaoyun, Li, Yupeng, Wen, Donghai, Long, Huoyou, Luo, Jinfeng, Feng, Yubing, Zhuang, Xiaoxi, Zhang, Fengxiang, Liu, Jianqi, Leng, Fang, Lang, Xingfen, Bai, Yang, She, Miaoqin, Tu, Zhengchao, Pan, Jingxuan, Ding, Ke
Published in Journal of medicinal chemistry (14.02.2013)
Published in Journal of medicinal chemistry (14.02.2013)
Get full text
Journal Article
HETEROCYCLIC ALKYNYL BENZENE COMPOUNDS AND MEDICAL COMPOSITIONS AND USES THEREOF
DING KE, LUO KUN, WANG DEPING, PEI DUANQING, ZHANG ZHANG, FENG YUBING, SHEN MENGJIE
Year of Publication 29.04.2013
Get full text
Year of Publication 29.04.2013
Patent